Article:
PanScan
The PanScan consortia was formed in 2006 to facilitate two genome-wide association studies, PanScan I and PanScan II, which have led to the discovery of four novel regions in the genome associated with risk for pancreatic cancer.
Website
Principal investigator or primary contact
Alan Arslan, Patricia Hartge
Primary phenotype
Secondary phenotype(s)
Number of GWAS Studies Contributing to the Consortium
20
Approx. total number of subjects
8000
GWAS data available
yes









